$5.22
-0.06-1.14%
At close: -
$5.20
-0.02-0.38%
After Hours: Mar 28, 7:54 PM EDT
Comments
Loading...
Verve Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VERV | Benzinga
Verve Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.740
Quarterly Revenue Estimate
$3.97M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$32.33M
Analyze the earnings history of Verve Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics | -$0.59 | -$0.74 | — | — | $5.70M | $3.97M | — | — | 05/07/2025 | Get Alert |
| VERV | Verve Therapeutics | -$0.69 | -$0.67 | -$0.58 | 13.43% | $5.14M | $4.94M | $13.08M | 164.78% | 02/27/2025 | Get Alert |
| VERV | Verve Therapeutics | -$0.72 | -$0.70 | -$0.59 | 15.71% | $3.12M | $2.81M | $6.87M | 144.31% | 11/05/2024 | Get Alert |
| VERV | Verve Therapeutics | -$0.87 | -$0.68 | -$0.59 | 13.24% | $2.09M | $2.40M | $6.69M | 178.83% | 08/08/2024 | Get Alert |
| VERV | Verve Therapeutics | -$0.84 | -$0.71 | -$0.59 | 16.90% | $1.40M | $2.02M | $5.70M | 181.93% | 05/08/2024 | Get Alert |
| VERV | Verve Therapeutics | -$0.67 | -$0.82 | -$0.69 | 15.85% | $1.01M | $1.17M | $5.14M | 339.57% | 02/27/2024 | Get Alert |
| VERV | Verve Therapeutics | -$0.79 | -$0.92 | -$0.72 | 21.74% | $929.00K | $960.00K | $3.12M | 224.69% | 11/07/2023 | Get Alert |
| VERV | Verve Therapeutics | -$0.84 | -$0.92 | -$0.87 | 5.43% | $0.00 | $760.00K | $2.09M | 175.39% | 08/10/2023 | Get Alert |
| VERV | Verve Therapeutics | -$0.62 | -$0.78 | -$0.84 | -7.69% | $0.00 | $510.00K | $1.40M | 175.29% | 05/15/2023 | Get Alert |
| VERV | Verve Therapeutics | -$0.65 | -$0.76 | -$0.67 | 11.84% | $0.00 | — | $1.01M | — | 03/02/2023 | Get Alert |
| VERV | Verve Therapeutics | -$0.47 | -$0.74 | -$0.79 | -6.76% | $0.00 | — | $929.00K | — | 11/07/2022 | Get Alert |
| VERV | Verve Therapeutics | -$6.66 | — | -$0.84 | — | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| VERV | Verve Therapeutics | -$4.99 | — | -$0.62 | — | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
| VERV | Verve Therapeutics | — | — | -$0.65 | — | — | — | $0.00 | — | 03/14/2022 | Get Alert |
| VERV | Verve Therapeutics | -$3.81 | — | -$0.47 | — | — | — | $0.00 | — | 11/10/2021 | Get Alert |
| VERV | Verve Therapeutics | -$3.41 | — | -$2.13 | — | — | — | $0.00 | — | 08/12/2021 | Get Alert |
Verve Therapeutics (VERV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.58 | $-0.67 | 13.4 % |
| Q3 | 2024-11-05 | $-0.59 | $-0.70 | 15.7 % |
| Q2 | 2024-08-08 | $-0.59 | $-0.68 | 13.2 % |
| Q1 | 2024-05-08 | $-0.59 | $-0.71 | 16.9 % |
Verve Therapeutics (VERV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $13.08M | $4.94M | 164.8 % |
| Q3 | 2024-11-05 | $6.87M | $2.81M | 144.3 % |
| Q2 | 2024-08-08 | $6.69M | $2.40M | 178.8 % |
| Q1 | 2024-05-08 | $5.70M | $2.02M | 181.9 % |
FAQ
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
Verve Therapeutics (VERV) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Verve Therapeutics (NASDAQ:VERV)?
The Actual EPS was $-0.58, which beat the estimate of $-0.67.
What were Verve Therapeutics’s (NASDAQ:VERV) revenues?
The Actual Revenue was $13.1M, which beat the estimate of $4.9M.
Browse earnings estimates, EPS, and revenue on all stocks.